CSL's Largest-Ever Clinical Trial for Recurrent Heart Attacks: High Unmet Medical Need
Blood product giant CSL Ltd (CSL AU) announced during its annual research & development briefing this morning that it will proceed with a Phase...
160 Views
Aussie Healthcare Daily: 1 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare & biotech companies as well as developments...
176 Views
Equity Asia Weekly Research - 11 Oct 2017
Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAPWhat's new from last week• Although ASX remains within its 3-month...
283 Views
Not All Players Are Equal in the Plasma Industry
According to Allied Market Research, the IVIG (intravenous IG) market was valued at US$7.86bn and is expected to reach US$12.36bn by 2022. IVIG is...
298 Views
China's Healthcare Reform Consolidates Drug Distribution and Cuts Manufacturer Margins
Rolling Out A “Two Invoices” System Nationwide:Although the announcement of a new policy to consolidate the distribution channels for both...
292 Views